BioCentury | Dec 15, 2020
Finance

Dec. 14 Quick Takes: Locanabio raises $100M series B; plus rare bleeding disorder newco Hemab, raises for Rani, CG, InnoSkel, Denovo, Biosion and more

...by CICC Qide Innovative Biomedical Investment Fund and Yingke PE, with participation by new investors China Resources Pharmaceutical...
...Fund Zheshang Innovest HighTide Therapeutics Inc. Greater Bay Area Homeland Development Fund Hangzhou Tigermed Consulting Co. Ltd. Citic Securities NeuroRx Inc. Alkermes plc China Resources Pharmaceutical Group Ltd. SVB...
BioCentury | Jun 29, 2018
Company News

Ascletis, CR Pharmaceutical partner to distribute HCV drug in Beijing

...Pharma Inc. (Hangzhou, China) partnered with the CR Pharmaceutical Commercial Group Co. Ltd. subsidiary of China Resources Pharmaceutical Group Ltd....
...Roche (SIX:ROG; OTCQX:RHHBY) in 2013 (see “Ascletis, Roche Deal” ). Ascletis Pharma Inc., Hangzhou, China China Resources Pharmaceutical Group Ltd....
...SIX:ROG; OTCQX:RHHBY), Basel, Switzerland Business: Infectious Alicia Parker Ganovo, danoprevir (ASC08, ITMN-191, RG7227, r7227, ITMN B) Ascletis Pharma Inc. China Resources Pharmaceutical Group Ltd. Roche HCV...
BioCentury | Apr 6, 2018
Finance

China’s exchange options

...the market cap standards for companies not listed overseas: Samsung BioLogics Co. Ltd. (KSE:207940) and China Resources Pharmaceutical Group Ltd....
BioCentury | Jan 13, 2018
Finance

Choosy investors

...by 4Q16’s $4.1 billion haul, but that figure was distorted by two massive Asian offerings; China Resources Pharmaceutical Group Ltd....
BioCentury | Oct 27, 2017
Financial News

China Resources planning China pharma fund

...of drug distribution company China Resources Pharmaceutical Group Ltd. (HKSE:3320) proposed to raise RMB2,500 million ($376.8 million) in its China Resources Pharmaceutical...
...its subsidiaries will contribute RMB305.3 million ($46 million) to the fund. China Resources Pharmaceutical Group Ltd. (HKSE:3320), Beijing, China Alicia Parker China Resources Pharmaceutical Group Ltd....
BioCentury | Oct 26, 2017
Financial News

China Resources planning China pharma fund

...of drug distribution company China Resources Pharmaceutical Group Ltd. (HKSE:3320) proposed to raise RMB2,500 million ($376.8 million) in its China Resources Pharmaceutical...
...companies. China Resources and its subsidiaries will contribute RMB305.3 million ($46 million) to the fund. Alicia Parker China Resources Pharmaceutical Group Ltd....
BioCentury | Jul 21, 2017
Company News

Cardinal seeking buyer for China distribution business

...was seeking a buyer for its Chinese business. Shanghai Pharmaceuticals Holding Co. Ltd. (HKSE:2607; Shanghai:601607), China Resources Pharmaceutical Group Ltd....
...the hospital (see BioCentury Extra, Jan. 24) . Chris Lieu Cardinal Health Inc. China National Pharmaceutical Group Corp. (Sinopharm) China Resources Pharmaceutical Group Ltd. Shanghai...
BioCentury | Jan 6, 2017
Finance

Good riddance

...by biomanufacturing company Samsung BioLogics Co. Ltd. (KOSDAQ:207940) and $1.8 billion by drug distribution company China Resources Pharmaceutical Group Ltd....
...SZSE:300558) 11/7/16 $106.3 $1,038.6 $4,258.5 310% Logos Biosystems Inc. (KOSDAQ:238120) 11/3/16 $16.3 $81.7 $48.6 -41% China Resources Pharmaceutical Group Ltd....
BioCentury | Dec 16, 2016
Company News

Sanofi, China Resources deal

...not respond to inquiries. Sanofi (Euronext:SAN; NYSE:SNY), Paris, France China Resources Pharmaceutical Group Ltd. (HKSE:3320), Beijing, China Business: Other Chris Lieu China Resources Pharmaceutical Group Ltd. Sanofi...
BioCentury | Oct 31, 2016
Financial News

China Resources Pharmaceutical completes IPO

China Resources Pharmaceutical Group Ltd. (HKSE:3320), Beijing, China Business: Pharmaceuticals Date completed: 2016-10-27 Type: IPO Raised: HK$14 billion ($1.8 billion) Shares: 1.5 billion Price: HK$9.10 Underwriters: BofA Merrill Lynch; CCB International Capital; China International Capital...
Items per page:
1 - 10 of 16
BioCentury | Dec 15, 2020
Finance

Dec. 14 Quick Takes: Locanabio raises $100M series B; plus rare bleeding disorder newco Hemab, raises for Rani, CG, InnoSkel, Denovo, Biosion and more

...by CICC Qide Innovative Biomedical Investment Fund and Yingke PE, with participation by new investors China Resources Pharmaceutical...
...Fund Zheshang Innovest HighTide Therapeutics Inc. Greater Bay Area Homeland Development Fund Hangzhou Tigermed Consulting Co. Ltd. Citic Securities NeuroRx Inc. Alkermes plc China Resources Pharmaceutical Group Ltd. SVB...
BioCentury | Jun 29, 2018
Company News

Ascletis, CR Pharmaceutical partner to distribute HCV drug in Beijing

...Pharma Inc. (Hangzhou, China) partnered with the CR Pharmaceutical Commercial Group Co. Ltd. subsidiary of China Resources Pharmaceutical Group Ltd....
...Roche (SIX:ROG; OTCQX:RHHBY) in 2013 (see “Ascletis, Roche Deal” ). Ascletis Pharma Inc., Hangzhou, China China Resources Pharmaceutical Group Ltd....
...SIX:ROG; OTCQX:RHHBY), Basel, Switzerland Business: Infectious Alicia Parker Ganovo, danoprevir (ASC08, ITMN-191, RG7227, r7227, ITMN B) Ascletis Pharma Inc. China Resources Pharmaceutical Group Ltd. Roche HCV...
BioCentury | Apr 6, 2018
Finance

China’s exchange options

...the market cap standards for companies not listed overseas: Samsung BioLogics Co. Ltd. (KSE:207940) and China Resources Pharmaceutical Group Ltd....
BioCentury | Jan 13, 2018
Finance

Choosy investors

...by 4Q16’s $4.1 billion haul, but that figure was distorted by two massive Asian offerings; China Resources Pharmaceutical Group Ltd....
BioCentury | Oct 27, 2017
Financial News

China Resources planning China pharma fund

...of drug distribution company China Resources Pharmaceutical Group Ltd. (HKSE:3320) proposed to raise RMB2,500 million ($376.8 million) in its China Resources Pharmaceutical...
...its subsidiaries will contribute RMB305.3 million ($46 million) to the fund. China Resources Pharmaceutical Group Ltd. (HKSE:3320), Beijing, China Alicia Parker China Resources Pharmaceutical Group Ltd....
BioCentury | Oct 26, 2017
Financial News

China Resources planning China pharma fund

...of drug distribution company China Resources Pharmaceutical Group Ltd. (HKSE:3320) proposed to raise RMB2,500 million ($376.8 million) in its China Resources Pharmaceutical...
...companies. China Resources and its subsidiaries will contribute RMB305.3 million ($46 million) to the fund. Alicia Parker China Resources Pharmaceutical Group Ltd....
BioCentury | Jul 21, 2017
Company News

Cardinal seeking buyer for China distribution business

...was seeking a buyer for its Chinese business. Shanghai Pharmaceuticals Holding Co. Ltd. (HKSE:2607; Shanghai:601607), China Resources Pharmaceutical Group Ltd....
...the hospital (see BioCentury Extra, Jan. 24) . Chris Lieu Cardinal Health Inc. China National Pharmaceutical Group Corp. (Sinopharm) China Resources Pharmaceutical Group Ltd. Shanghai...
BioCentury | Jan 6, 2017
Finance

Good riddance

...by biomanufacturing company Samsung BioLogics Co. Ltd. (KOSDAQ:207940) and $1.8 billion by drug distribution company China Resources Pharmaceutical Group Ltd....
...SZSE:300558) 11/7/16 $106.3 $1,038.6 $4,258.5 310% Logos Biosystems Inc. (KOSDAQ:238120) 11/3/16 $16.3 $81.7 $48.6 -41% China Resources Pharmaceutical Group Ltd....
BioCentury | Dec 16, 2016
Company News

Sanofi, China Resources deal

...not respond to inquiries. Sanofi (Euronext:SAN; NYSE:SNY), Paris, France China Resources Pharmaceutical Group Ltd. (HKSE:3320), Beijing, China Business: Other Chris Lieu China Resources Pharmaceutical Group Ltd. Sanofi...
BioCentury | Oct 31, 2016
Financial News

China Resources Pharmaceutical completes IPO

China Resources Pharmaceutical Group Ltd. (HKSE:3320), Beijing, China Business: Pharmaceuticals Date completed: 2016-10-27 Type: IPO Raised: HK$14 billion ($1.8 billion) Shares: 1.5 billion Price: HK$9.10 Underwriters: BofA Merrill Lynch; CCB International Capital; China International Capital...
Items per page:
1 - 10 of 16